CLINICAL ROLE -
Immune System May Hold Key to Curing HIV
Kick and kill strategy uses vaccine to stimulate immune system.
Read More
In Case You Missed It: Specialty Pharmacy Times Week in Review
A look back at some of the top stories on Specialty Pharmacy Times from April 13-17.
New Drug for Blood Cancers May Overcome Treatment Resistance
Treatment will be available for clinical trials in patients with certain types of leukemia and non-Hodgkin lymphomas later this year.
Added Benefit of Lung Cancer Drug Depends on Disease Severity
Combination of nintedanib with docetaxel primarily depends on whether patients already had brain metastases.
Newly Insured Shift Prescription Trends Substantially
States with expanded Medicaid saw 25% more prescriptions filled last year.
States with expanded Medicaid saw 25% more prescriptions filled than the prior year.
Muscle Building Supplements Linked to Testicular Cancer
Supplements containing creatine or androstenedione significantly increase disease risk.
Specialty Drugs Drive US Medicine Spending Spike
A record 4.3 billion prescriptions were filled in the United States last year.
Some Sections of Female Reproductive Tract More Susceptible to HIV Infection
Specific type of lymphocyte found to impact HIV infection.
Patient Death Leads to Warning Label Change for Hepatitis C Drug
Co-administration of amiodarone with simeprevir and sofosbuvir combination is not recommended.
Inflammatory Bowel Disease Drug Effective in Treatment of Diabetes
Treatment found to lower blood sugar levels in obese mice.
Experimental Therapy Suppresses HIV Infection
Treatment dramatically reduces viral load in blood.
New Prostate Cancer Treatment May Provide Cost Effective Alternative
Low temperature plasmas found to induce high levels of DNA damage.
US Bioservices Customizes Patient Care
US Bioservices offers nationwide specialty pharmacy and nursing services tailored to meet the needs of patients, physicians, payers, and manufacturers.
Researchers on Verge of Breakthrough New Class of Cancer Drugs
Inhibiting a previously undruggable protein holds promise for treatment of numerous types of cancer.
Treating Patients in Prison with New Hepatitis C Drugs Could Break Budgets
High cost of new drugs make treating even the sickest inmates impractical.
Telomere Length Impacts Cancer Mortality
Longer telomeres gives cancer cells a survival advantage.
Allergy Drug Limits Hepatitis C Activity
CCZ impairs the ability of the virus to enter human liver cells.
Sustained Benefit After Two Years From Rare Blood Cancer Drug
Ibrutinib found to control Waldenstrom's Macroglobulinemia in 95% of patients.
Genetic Mutations Carry Different Risks for Breast, Ovarian Cancer
Analysis of cancer-causing mutations in the BRCA1 or BRCA2 genes may lead to more effective treatments.
Interventions Drastically Improve Adherence in Minorities with HIV
Lack of adherence remains a major source of health care costs among HIV patients.
Researchers Urge Surgeon General to Announce UV Tanning Causes Skin Cancer
Study finds that UV tanning meets the same criteria as smoking as a cause of cancer.
A look back at some of the top stories on Specialty Pharmacy Times from April 6-10.
Early Onset of Age-Related Illnesses Common in HIV Patients
Accelerated aging of DNA can lead to diseases such as cancer and osteoporosis.
Brain Boosting Multiple Sclerosis Treatments Benefit Patients
Increased neuron activity helps to protect nerve fibers.
Treatment Causes Immune Cell Rebound in Children with HIV
Vast majority of children with HIV experience recovery of immune system following therapy.
Economic, Racial Health Care Disparities Persist Despite ACA
Researchers suggest financial incentives to reward patient-centered care.
Existing Leukemia Drug Shows Potential in Colon Cancer Treatment
Enzyme blocker reduces growth of intestinal tumors.
People Over 65 Years Seven Times More Likely to Get Melanoma than 40 Years Ago
Prevalence of tanning linked to sharp increase in melanoma risk.